ADC Therapeutics SA (ADCT) reported Q3 EPS of ($0.65), $0.30 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $76.32 million versus the consensus estimate of $60.7 million.
ADC Therapeutics SA (ADCT) reported Q3 EPS of ($0.65), $0.30 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $76.32 million versus the consensus estimate of $60.7 million.